Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FE617
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,974
Award facts
- Contract value 100% obligated
- $18,973.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,973.90 to AmerisourceBergen Drug Corp on November 5, 2025, under a firm fixed price, competitive procurement. The order is set to be completed by November 6, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is part of the company's ongoing support for the Defense Health Agency and other government healthcare systems through the comprehensive SPE2DX contract vehicle, which carries a potential value of $999,999,999 through December 2026.
As a prime vendor under the DLA Troop Support Medical contract, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities, including brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals across multiple therapeutic domains. This particular delivery order exemplifies the company's role in fulfilling federal medical supply requirements through competitive procurement mechanisms. The contract reflects AmerisourceBergen's significant capacity to meet strategic military healthcare supply chain objectives, particularly as the DLA prepares to establish the Pharmaceutical Prime Vendor Global Program Generation V with multiple regional awards across several contractors.
Quick answers
Who was awarded contract SPE2DU26FE617?
SPE2DU26FE617 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DU26FE617 worth?
The government has obligated $18,974 on SPE2DU26FE617.
Is contract SPE2DU26FE617 an order under another contract?
Yes. SPE2DU26FE617 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE617 competed?
The extent of competition for SPE2DU26FE617 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award